> Cancer diagnostics startup Celcuity filed to raise up to $15 million in an IPO. The Minneapolis-based company is working on its CELx platform, which analyzes live tissue to pinpoint the specific abnormal activity that drives a patient's cancer. Release
> The FDA cleared Titan Pharmaceuticals' phase 1/2 clinical study of its ropinirole-delivering implant for the treatment of Parkinson's disease. Release
